In GC, one major issue concerned the existing body of research suggested that METTL3 was overexpressed and promoted GC progression [11, 19, 23, 24], while downregulated METTL14 acted as a tumor suppressor [25, 26]. This evidence concerns the gene METTL3 and gastric cancer.